
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
FMCCL | OTC Markets | USD | Delayed | |
FMCC | OTC Markets | USD | Delayed | |
FMCKO | OTC Markets | USD | Delayed | |
FMCKM | OTC Markets | USD | Delayed | |
FMCKL | OTC Markets | USD | Delayed | |
FMCKI | OTC Markets | USD | Delayed | |
FMCKJ | OTC Markets | USD | Delayed | |
FREJN | OTC Markets | USD | Delayed | |
FREJP | OTC Markets | USD | Delayed | |
FMCCN | OTC Markets | USD | Delayed | |
FMCCM | OTC Markets | USD | Delayed | |
FMCCT | OTC Markets | USD | Delayed | |
FMCCG | OTC Markets | USD | Delayed | |
FMCCS | OTC Markets | USD | Delayed | |
FMCCK | OTC Markets | USD | Delayed | |
FMCKK | OTC Markets | USD | Delayed | |
FMCCI | OTC Markets | USD | Delayed | |
FMCKP | OTC Markets | USD | Delayed | |
FMCCH | OTC Markets | USD | Delayed | |
FMCCJ | OTC Markets | USD | Delayed | |
FMCCO | OTC Markets | USD | Delayed | |
FMCCP | OTC Markets | USD | Delayed | |
FMCKN | OTC Markets | USD | Delayed | |
FREGP | OTC Markets | USD | Delayed |
Period Ending: | 2023 31/03 |
2022 31/12 |
2022 30/09 |
2022 30/06 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 4432 | - | 3385 | 5097 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | - | - | - | - | ||||||||||||||||||||||||||||||
Gross Profit | 4432 | 4258 | 3385 | 5097 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 1932 | 2042 | 1825 | 2020 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 2500 | 2216 | 1560 | 3077 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | - | - | - | ||||||||||||||||||||||||||||||
Other, Net | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Taxes | 2500 | 2216 | 1560 | 3077 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 505 | 453 | 247 | 624 | ||||||||||||||||||||||||||||||
Net Income After Taxes | 1995 | 1763 | 1313 | 2453 | ||||||||||||||||||||||||||||||
Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | 1995 | - | 1313 | 2453 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | 1995 | - | 1313 | 2453 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | -2049 | -1788 | -1132 | -2387 | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | -54 | -25 | 181 | 66 | ||||||||||||||||||||||||||||||
Dilution Adjustment | 2049 | 1788 | 1132 | 2387 | ||||||||||||||||||||||||||||||
Diluted Net Income | -54 | -25 | 181 | 66 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 3234 | 3234 | 3234 | 3234 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | -0.017 | -0.008 | 0.056 | 0.02 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | 0.483 | 0.428 | 0.301 | 0.595 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review